Guardant Health (GH) PT Raised to $55 at BTIG
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Raymond James Reiterates Outperform Rating on Guardant Health (GH)
January 21, 2025 1:00 PM ESTRaymond James analyst Andrew Cooper reiterated an Outperform rating and $39.00 price target on Guardant Health (NASDAQ: GH)
The analyst comments "Net-net, this coverage news offers avenues for both volume and ASP accelerations for Reveal specifically and for the broader Guardant portfolio overall.... More
Raymond James Reiterates Outperform Rating on Guardant Health (GH)
January 21, 2025 1:00 PM ESTRaymond James analyst Andrew Cooper reiterated an Outperform rating and $39.00 price target on Guardant Health (NASDAQ: GH)
The analyst comments "Net-net, this coverage news offers avenues for both volume and ASP accelerations for Reveal specifically and for the broader Guardant portfolio overall.... More
TD Cowen Reiterates Buy Rating on Guardant Health (GH)
January 21, 2025 11:50 AM ESTTD Cowen analyst Dan Brennan reiterated a Buy rating and $42.00 price target on Guardant Health (NASDAQ: GH).
The analyst comments "This morning GH announced its MRD test, Reveal, received MolDX coverage in the recurrence CRC setting. Mgmt guided for such approval... More
